KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Retained Earnings (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Retained Earnings for 7 consecutive years, with -$1.4 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 2.11% to -$1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 billion through Dec 2025, up 2.11% year-over-year, with the annual reading at -$1.4 billion for FY2025, 2.11% up from the prior year.
  • Retained Earnings hit -$1.4 billion in Q4 2025 for GoodRx Holdings, roughly flat from -$1.4 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$1.4 billion in Q2 2021 to a low of -$1.5 billion in Q1 2024.
  • Historically, Retained Earnings has averaged -$1.4 billion across 5 years, with a median of -$1.4 billion in 2025.
  • Biggest five-year swings in Retained Earnings: dropped 25.97% in 2021 and later grew 2.38% in 2025.
  • Year by year, Retained Earnings stood at -$1.4 billion in 2021, then decreased by 2.32% to -$1.4 billion in 2022, then fell by 0.61% to -$1.5 billion in 2023, then rose by 1.12% to -$1.4 billion in 2024, then increased by 2.11% to -$1.4 billion in 2025.
  • Business Quant data shows Retained Earnings for GDRX at -$1.4 billion in Q4 2025, -$1.4 billion in Q3 2025, and -$1.4 billion in Q2 2025.